Report Detail
Global Poliomyelitis Vaccines Market Insights, Forecast to 2025
- RnM3234608 |
- 02 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Poliomyelitis Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Poliomyelitis Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Poliomyelitis Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Poliomyelitis Vaccines in these regions.
This research report categorizes the global Poliomyelitis Vaccines market by top players/brands, region, type and end user. This report also studies the global Poliomyelitis Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market size by Product
IPV
OPV
Market size by End User
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Poliomyelitis Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Poliomyelitis Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Poliomyelitis Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Poliomyelitis Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Poliomyelitis Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Poliomyelitis Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Poliomyelitis Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Poliomyelitis Vaccines Market Size Growth Rate by Product
- 1.4.2 IPV
- 1.4.3 OPV
- 1.5 Market by End User
- 1.5.1 Global Poliomyelitis Vaccines Market Size Growth Rate by End User
- 1.5.2 Research & Academic Laboratories
- 1.5.3 Pharmaceutical & Biotechnology Companies
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Poliomyelitis Vaccines Market Size
- 2.1.1 Global Poliomyelitis Vaccines Revenue 2014-2025
- 2.1.2 Global Poliomyelitis Vaccines Sales 2014-2025
- 2.2 Poliomyelitis Vaccines Growth Rate by Regions
- 2.2.1 Global Poliomyelitis Vaccines Sales by Regions
- 2.2.2 Global Poliomyelitis Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Poliomyelitis Vaccines Sales by Manufacturers
- 3.1.1 Poliomyelitis Vaccines Sales by Manufacturers
- 3.1.2 Poliomyelitis Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Poliomyelitis Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Poliomyelitis Vaccines Revenue by Manufacturers
- 3.2.1 Poliomyelitis Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Poliomyelitis Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Poliomyelitis Vaccines Price by Manufacturers
- 3.4 Poliomyelitis Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Poliomyelitis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Poliomyelitis Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Poliomyelitis Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Poliomyelitis Vaccines Sales by Product
- 4.2 Global Poliomyelitis Vaccines Revenue by Product
- 4.3 Poliomyelitis Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Poliomyelitis Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Poliomyelitis Vaccines by Countries
- 6.1.1 North America Poliomyelitis Vaccines Sales by Countries
- 6.1.2 North America Poliomyelitis Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Poliomyelitis Vaccines by Product
- 6.3 North America Poliomyelitis Vaccines by End User
7 Europe
- 7.1 Europe Poliomyelitis Vaccines by Countries
- 7.1.1 Europe Poliomyelitis Vaccines Sales by Countries
- 7.1.2 Europe Poliomyelitis Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Poliomyelitis Vaccines by Product
- 7.3 Europe Poliomyelitis Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Poliomyelitis Vaccines by Countries
- 8.1.1 Asia Pacific Poliomyelitis Vaccines Sales by Countries
- 8.1.2 Asia Pacific Poliomyelitis Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Poliomyelitis Vaccines by Product
- 8.3 Asia Pacific Poliomyelitis Vaccines by End User
9 Central & South America
- 9.1 Central & South America Poliomyelitis Vaccines by Countries
- 9.1.1 Central & South America Poliomyelitis Vaccines Sales by Countries
- 9.1.2 Central & South America Poliomyelitis Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Poliomyelitis Vaccines by Product
- 9.3 Central & South America Poliomyelitis Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Poliomyelitis Vaccines by Countries
- 10.1.1 Middle East and Africa Poliomyelitis Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Poliomyelitis Vaccines by Product
- 10.3 Middle East and Africa Poliomyelitis Vaccines by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Poliomyelitis Vaccines Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Poliomyelitis Vaccines Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Bibcol
- 11.3.1 Bibcol Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bibcol Poliomyelitis Vaccines Products Offered
- 11.3.5 Bibcol Recent Development
- 11.4 Serum Institute
- 11.4.1 Serum Institute Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Serum Institute Poliomyelitis Vaccines Products Offered
- 11.4.5 Serum Institute Recent Development
- 11.5 Tiantan Biological
- 11.5.1 Tiantan Biological Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Tiantan Biological Poliomyelitis Vaccines Products Offered
- 11.5.5 Tiantan Biological Recent Development
- 11.6 IMBCA
- 11.6.1 IMBCA Company Details
- 11.6.2 Company Business Overview
- 11.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 IMBCA Poliomyelitis Vaccines Products Offered
- 11.6.5 IMBCA Recent Development
- 11.7 Panacea Biotec Ltd
- 11.7.1 Panacea Biotec Ltd Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Products Offered
- 11.7.5 Panacea Biotec Ltd Recent Development
- 11.8 Bio-Med
- 11.8.1 Bio-Med Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bio-Med Poliomyelitis Vaccines Products Offered
- 11.8.5 Bio-Med Recent Development
- 11.9 Halfkin Bio-Pharmaceuticals
- 11.9.1 Halfkin Bio-Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Products Offered
- 11.9.5 Halfkin Bio-Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Poliomyelitis Vaccines Market Forecast by Regions
- 12.1.1 Global Poliomyelitis Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Poliomyelitis Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Poliomyelitis Vaccines Market Forecast by Product
- 12.2.1 Global Poliomyelitis Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Poliomyelitis Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Poliomyelitis Vaccines Market Forecast by End User
- 12.4 North America Poliomyelitis Vaccines Forecast
- 12.5 Europe Poliomyelitis Vaccines Forecast
- 12.6 Asia Pacific Poliomyelitis Vaccines Forecast
- 12.7 Central & South America Poliomyelitis Vaccines Forecast
- 12.8 Middle East and Africa Poliomyelitis Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Poliomyelitis Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Poliomyelitis Vaccines. Industry analysis & Market Report on Poliomyelitis Vaccines is a syndicated market report, published as Global Poliomyelitis Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Poliomyelitis Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
